CClinicalTrials.gg
Sign In
Status unknownNCT04394429TubeObs-CovidUpdated Jan 8, 2021

Endotracheal Tube Obstruction in Covid-19 Patients Requiring Mechanical Ventilation

An observational study in Sars-CoV2, sponsored by University Hospital, Strasbourg, France. Status unknown at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-01-08.

Sponsored by University Hospital, Strasbourg, France · Observational

The sponsor has not verified this record recently (last verified May 2020), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Case-only
Time perspective
Other
Enrollment
184
Ages
18 Years and older
Sex
All
01

Study summary

The COVID-19 pandemic is very present in our region, the Grand-Est region is considered as one of the first COVID-19 epicentres in France. COVID-19 causes an acute respiratory distress syndrome requiring prolonged mechanical ventilation in resuscitation.

02

Conditions studied

  • Sars-CoV2

Browse trials for

Keywords

  • Endotracheal Tube
  • ETT
  • Intubation
  • Mechanical ventilation
  • Endotracheal tube obstruction
  • ICU
  • Covid-19
  • SARS-CoV-2
  • ARDS
03

In context

COVID-19

7,640 studies on the registry are indexed under COVID-19; 488 are open to participants now.

This study's planned enrollment of 184 is below the median of 261 across 3,136 observational studies indexed under COVID-19.

Browse COVID-19 studies →

Lead sponsor

University Hospital, Strasbourg, France is the lead sponsor of 966 studies on the registry; 342 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Subject with COVID 19 hospitalized in the intensive care unit at the NHC of the University Hospitals of Strasbourg

Inclusion criteria

  • Major Subject (≥18 years)
  • Subject with COVID 19 (radiological suspicion or microbiological confirmation)
  • Subject hospitalised in the intensive care unit at the NHC of the University Hospitals of Strasbourg between 01/03/2020 and 03/04/2020.
  • Subject treated by mechanical ventilation
  • Subject who has not expressed his opposition, after information, to the re-use of his data for the purposes of this research

Translated with www.DeepL.com/Translator (free version)

Exclusion criteria

Exclusion Criteria:

  • Subject who expressed opposition to participating in the study
  • Subject under guardianship, curatorship or safeguarding of justice
05

Study design

Observational model
Case-only
Time perspective
Other
Enrollment
184 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Analysis of risk factors for intubation tube obstruction

    Time frame: 1 month

07

Study locations

1 of 1 sites recruiting
  • Service d'Anesthésie-Réanimation - Nouvel Hôpital Civil
    Strasbourg, 67091, France
    • Bob HEGER, MD · Contact · Bob.Heger@chru-strasbourg.fr · 33 3.69.55.04.43
    • Saïd CHAYER, PhD, HDR · Contact · said.chayer@chru-strasbourg.fr · 33 3 88 11 66 90
    • Bob HEGER, MD · Principal investigator
    • Olivier COLLANGE, MD, PhD · Sub investigator
    • Paul-Michel MERTES, MD, PhD · Sub investigator
    • Martin PETIT, MD · Sub investigator
    • Alexandra MONNIER, MD · Sub investigator
    • Ferhat MEZIANI, MD, PhD · Sub investigator
    • François SEVERAC, MD · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04394429
Lead sponsor
University Hospital, Strasbourg, France
Responsible party
Sponsor
First posted
May 19, 2020
Start date
Apr 24, 2020
Primary completion
Jun 24, 2021 (estimated)
Completion
Jun 24, 2021 (estimated)
Last update
Jan 8, 2021

Study contacts

Bob HEGER, MD
Contact
Bob.Heger@chru-strasbourg.fr
33 3.69.55.04.43
Saïd CHAYER, PhD, HDR
Contact
said.chayer@chru-strasbourg.fr
33 3 88 11 66 90
Bob HEGER
study director · Anesthesia-Resuscitation Department - Strasbourg University Hospitals

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

COVID-19→

Other studies from this sponsor

University Hospital, Strasbourg, France

Start the discussion